Skip to Main Content
Insider Trading

Thomas J Mcinerney Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 12 hours ago

Thomas J Mcinerney has an estimated net worth of at least $43.1 million*, as of yesterday. They own 4.6 million shares of GNW stock. They have sold 1.6 million shares of GNW stock since 2021, for an estimated $8.4 million.

Thomas J Mcinerney $GNW SEC Form 4 Insider Trading

Thomas J Mcinerney has filed a total of 10 insider trades in $GNW since 2021. Their most recent trade was a sale of 150,000 shares, made on Aug 26, 2024. Their largest trade was a sale of 200,000 shares, made on May 24, 2024. We estimate that they now own 4.6 million shares of $GNW, worth an estimated $34.6 million.



Insider Trading at $GNW

There have been a total of 14 insider trades reported at $GNW since 2021, with 50,000 shares purchased and 2.3 million shares sold. The most active insider traders in $GNW stock have been Thomas J Mcinerney, Daniel J Iv Sheehan, and Rohit Gupta. The most recent trade was a sale of 150,000 shares reported by Thomas J McInerney (President and CEO; Director), made on Aug 26, 2024.



History of Insider Stock Trades by Thomas J Mcinerney

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
GNW Sale 150,000 Aug 26, 2024 Aug. 27, 2024, 4:59 p.m.
GNW Sale 200,000 May 24, 2024 May 28, 2024, 5:02 p.m.
GNW Sale 200,000 Dec 04, 2023 Dec. 5, 2023, 5:15 p.m.
GNW Sale 200,000 Aug 11, 2023 Aug. 14, 2023, 5:01 p.m.
GNW Sale 125,000 May 22, 2023 May 23, 2023, 5 p.m.
GNW Sale 200,000 Nov 04, 2022 Nov. 8, 2022, 5:30 p.m.
GNW Sale 100,000 Aug 08, 2022 Aug. 10, 2022, 4:45 p.m.
GNW Sale 100,000 May 24, 2022 May 26, 2022, 4:13 p.m.
GNW Sale 150,000 Feb 22, 2022 Feb. 24, 2022, 5:45 p.m.
GNW Sale 150,000 Nov 15, 2021 Nov. 15, 2021, 8 p.m.




$GNW Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.